Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomePreferred Dividend PaymentsProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Benitec Biopharma (BNTC) Gross Profit: 2019-2023

Historic Gross Profit for Benitec Biopharma (BNTC) over the last 2 years, with Jun 2023 value amounting to $7,000.

  • Benitec Biopharma's Gross Profit was N/A to $7,000 in Q2 2023 from the same period last year, while for Jun 2023 it was $123,000, marking a year-over-year change of. This contributed to the annual value of $75,000 for FY2023, which is 17.19% up from last year.
  • Per Benitec Biopharma's latest filing, its Gross Profit stood at $7,000 for Q2 2023, which was down 87.04% from $54,000 recorded in Q1 2023.
  • Benitec Biopharma's Gross Profit's 5-year high stood at $54,000 during Q1 2023, with a 5-year trough of -$229,000 in Q4 2019.
  • Over the past 3 years, Benitec Biopharma's median Gross Profit value was $14,000 (recorded in 2022), while the average stood at $20,429.
  • Per our database at Business Quant, Benitec Biopharma's Gross Profit crashed by 1,228.57% in 2020 and then skyrocketed by 900.00% in 2022.
  • Over the past 5 years, Benitec Biopharma's Gross Profit (Quarterly) stood at -$229,000 in 2019, then skyrocketed by 92.14% to -$18,000 in 2020, then skyrocketed by 238.89% to $25,000 in 2021, then crashed by 44.00% to $14,000 in 2022, then climbed by 12.50% to $7,000 in 2023.
  • Its last three reported values are $7,000 in Q2 2023, $54,000 for Q1 2023, and $14,000 during Q4 2022.